News / Press Releases - July 1, 2026
Brussels, 1 July 2026 The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is pleased to announce the appointment of Dr. Thomas Ecker as Senior Expert on Joint Clinical Assessments (JCA), reinforcing the Association’s commitment to supporting members in the implementation of the European Health Technology Assessment… read more
News / Press Releases - June 17, 2026
Brussels, 17 June 2026 EUCOPE welcomes Diego Ardigò as new Chair of the EUCOPE Board. Diego brings deep scientific and clinical development expertise and a strong commitment to advancing an innovation ecosystem that works for patients, healthcare systems and health technology companies across Europe. As we… read more
News / Press Releases - June 9, 2026
Brussels 9 June 2026 The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) takes note of today’s publication of the first Joint Clinical Assessment (JCA) report. This marks a critical milestone in the implementation of the Regulation (EU) 2021/2282 on health technology assessment. Over the coming 18… read more
News / Press Releases - May 12, 2026
Brussels, 12 May 2026 The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), representing mostly small- to mid-sized innovative pharmaceutical companies in the EU, takes note of today’s provisional trilogue agreement on the Critical Medicines Act (CMA), reached by the EU Institutions. EUCOPE views this agreement as… read more
News / Press Releases - March 18, 2026
EUCOPE, representing mostly small and mid-sized innovative pharmaceutical companies in the EU, acknowledges today’s vote on the compromise text of the EU General Pharmaceutical Legislation (GPL) by the European Parliament’s Committee on Public Health (SANT). Following endorsement by Member States in COREPER on 6 March,… read more
News / Press Releases - January 20, 2026
Brussels, 20 January 2026 – The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) acknowledges today’s adoption of the Critical Medicines Act (CMA) by the European Parliament, which upholds the approach set out in the Public Health Committee (SANT) report endorsed in December 2025. EUCOPE reiterates the… read more
News / Press Releases - January 19, 2026
Findings to be discussed in EUCOPE webinar on 4 February 2026 Brussels, January 2026 – A new study quantifying the economic footprint of the small to mid-sized biopharmaceutical industry as represented by EUCOPE shows that EUCOPE member companies make a substantial contribution to the EU27… read more
Press Releases - December 17, 2025
Brussels, 17 December 2025 – The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) recognises the publication of the European Biotech Act Part I, as a promising initiative. This Act acknowledges biotechnology and biomanufacturing as strategic pillars for the EU’s competitiveness, health resilience and scientific leadership. EUCOPE… read more
Press Releases - December 16, 2025
On 15 December 2025, the European Parliament Public Health Committee (SANT) adopted its report on the Critical Medicines Act (CMA). The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) deems that the adopted text marks a troubling shift away from the CMA’s original purpose: addressing shortages of… read more
Press Releases - December 11, 2025
The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) acknowledges the provisional political agreement reached on the EU General Pharmaceutical Legislation (GPL) and recognises the efforts of the EU Institutions to modernise the pharmaceutical framework for the first time in over 20 years. This revision will have… read more
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information